NVS(Novartis AG) 的财务报表:医疗保健,综合制药。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | — | — | — | — | — |
| 毛利润 | $32.24B | $31.88B | $34.19B | $38.90B | $42.98B |
| 营业利润 | $10.06B | $7.95B | $9.77B | $14.54B | $17.64B |
| 净利润 | $24.02B | $6.96B | $14.85B | $11.94B | $13.98B |
| 经营现金流 | $15.07B | $14.24B | $14.46B | $17.62B | $19.14B |
| 自由现金流 | $14.01B | $13.32B | $13.40B | $16.25B | $17.60B |
| 摊薄每股收益 | $10.63 | $3.17 | $7.10 | $5.87 | $7.15 |